Avalon Investment & Advisory Galapagos Nv Transaction History
Avalon Investment & Advisory
- $3.56 Billion
- Q1 2023
Shares
2 transactions
Others Institutions Holding GLPG
# of Institutions
90Shares Held
13.2MCall Options Held
213KPut Options Held
126K-
Tang Capital Management LLC San Diego, CA2.16MShares$57.8 Million4.46% of portfolio
-
Bvf Inc San Francisco, CA1.57MShares$42 Million1.62% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.41MShares$37.7 Million0.96% of portfolio
-
Prosight Management, LP Dallas, TX1.03MShares$27.4 Million8.37% of portfolio
-
Deep Track Capital, LP Greenwich, CT781KShares$20.9 Million0.95% of portfolio
About GALAPAGOS NV
- Ticker GLPG
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,835,500
- Market Cap $1.76B
- Description
- Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...